SCHEMBL15636245

SCHEMBL15636245

O=C(O)CC(NC(=O)c1cc(O)n(-c2ccc(Cl)cc2)n1)c1cc(F)ccc1C(F)(F)F

nearest known ligand 0.47

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
▸ CTSA P10619 16/20 0.47
▸ CCR1 P32246 2/20 0.42
▸ MME P08473 2/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ KDM4E B2RXH2 1/20 0.41
▸ LMNA P02545 1/20 0.41
▸ MAPT P10636 1/20 0.41
▸ HTT P42858 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ NPSR1 Q6W5P4 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15636933 0.93 CTSA (0.50) CTSAMMECYP3A4
SCHEMBL16223822 0.92 CTSA (0.48) CTSA
SCHEMBL15635849 0.90 MME (0.51) CTSAMMECYP3A4
SCHEMBL15637449 0.90 CTSA (0.49) CTSAMMECYP3A4
SCHEMBL15635729 0.89 CTSA (0.49) CTSAMMECYP3A4
SCHEMBL16223771 0.88 CTSA (0.51) CTSAMMECYP3A4
SCHEMBL15637066 0.87 CTSA (0.55) CTSAMMECYP3A4
SCHEMBL15637664 0.86 CTSA (0.49) CTSACCR1MMECYP3A4KDM4E
SCHEMBL2317278 0.86 CTSA (0.49) CTSAMMECYP3A4
SCHEMBL15636475 0.86 CTSA (0.55) CTSAMMECYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2826772-A1 Intermediates for the synthesis of oxygen-substituted 3-heteroaroylamino-propionic acid derivatives SANOFI (FR) 2015-01-21 — — EP disclosed
EP-2528902-B1 OXYGEN-SUBSTITUTED 3-HETEROAROYLAMINO-PROPIONIC ACID DERIVATIVES AND THEIR USE AS PHARMACEUTICALS SANOFI SA (FR) 2014-11-12 — — EP disclosed
WO-2014053533-A1 USE OF SUBSTITUTED 3-HETEROAROYLAMINO-PROPIONIC ACID DERIVATIVES AS PHARMACEUTICALS FOR PREVENTION/TREATMENT OF ATRIAL FIBRILLATION SANOFI (FR) 2014-04-10 — — WO disclosed
Send feedback